Member Info for Safy

Sam,

I remember you from early Tils days.

If you want high risk and some decent gains then you could buy in but accept it could go down before up.

Alternatively wait for an approval to go through and then buy. Less risk.

None of the covid stocks apart from NCYT are actually selling atm.

@flying

If we get rejected do we actually find out or would the silence be an indication that we didn’t get in.

The approval rate is not great. Which isn’t a bad thing tbh. Poor tests don’t clog up the market.

No Ken,

I’m serious mate. It’s education for some of us.

Ken

Pls keep posting your US tips on here.

Hi Cola

65% on what price?

GDR is around 60% too.

Hillbilly

I did write 8-10 :) but I’m not a ramper so I had to be sure.

So it seems we are 10-12 dollars per test. And I bet if push comes to shove there can be some efficiencies in there so maybe $9 a test.

I wonder how this compares to the NCYT cost?
Are we better and cheaper or just better?

I think some people have mentioned before that they are in both GDR and NCYT. Can someone pls advise what the cost of the NCYT test is and margin they operate on.

And likewise can someone please mention the margins for the GDR test. I think DB said £8-10 but I’m not certain.

Hi Flyingmachine

What’s latest on ICMR?

Hereshopin

it looks like it updated on the LSE to 36.20

Dave,

I suggest reading up on the Crowdcity stuff already on this site, we seem to be quite far advanced with our test and raising awareness within the NHS and PHE. It seems were on their register now.

Scart, i dont know what to make of that claim (DB)

Honestly his competence just beggars belief by the day, if you read the RNS, they wrote date for WHO, ICMR and no date for FDA. Why would they do that?

Reading this from the FDA rule book.

'EUA submission pending: Test manufacturers have indicated that they have submitted an EUA application. FDA requires labs and commercial manufacturers to submit an EUA request within 10 days (serological test) or 15 days (molecular test) of completing test validation.'

If they went in on 10th June, they should be well past this 15 day deadline, if they went in as per the internet archive stuff ive found, then they've hit the deadline today. Either way the EUA request with test validation should be with FDA right now.

Most of us people are clued up about how business works these days.

GDR give you the BS about market sensitive etc etc, but nearly every single thing in the trading RNS could have been communicated to us prior to the RNS and i would wager anyone that our current SP would not be anywhere as low as it is today.

https://www.londonstockexchange.com/stock/ODX/omega-diagnostics-group-plc/company-page

35p closing

Im hoping Jimmy can help here, but it seems like its 15 days from between 17th and 24th June to submit a request...what a request means and in what context i have no idea, needless to say that their 15 days in up today.

'EUA submission pending: Test manufacturers have indicated that they have submitted an EUA application. FDA requires labs and commercial manufacturers to submit an EUA request within 10 days (serological test) or 15 days (molecular test) of completing test validation.'

My 45 day was just a guess Anna based on eyeballing dates and when the Covid peaks were. If NCYT got it in March, then they must have put in earliest end of Jan. It wont have been quiet then, and busy now. If anything the process will be far more streamlined now.

And i've tried to look at recent approvals and prior status as blank or pending like us and the ones i've checked dont have a prior entry. They go straight into the register as approved. Im sure there must be some but im not spending hours trying to decipher this.

Yes Dr Long,

I've told you MANY MANY times but you dont listen and argue back.

Their PR machine is fecking AWESOME, their CEO is informative, communicative, just having someone keep telling you that this is coming or that is coming keeps people engaged. When their CEO isnt talking, they have a group of very highly reputed investors who do very good comprehensive write ups about where the company is.

Our CEO has been missing in action for weeks. Even after the SP has tanked our CEO is silent. When theirs tanked they put out news regularly to keep up morale.

Kenbob

Good luck pal, i wish i could swap your 700 loss. To be honest mate, I think you have made a wise choice. To learn how the traders on here work, you would have needed to spend months on the boards and not just one share and even then its a steep learning curve. Take a hit and sleep better for it.

The lengths we are having to go to, to dig deep is fecking insane. Im checking internet archive pages going back weeks and looking for clues because the company is silent.

EUA submission pending: Test manufacturers have indicated that they have submitted an EUA application. FDA requires labs and commercial manufacturers to submit an EUA request within 10 days (serological test) or 15 days (molecular test) of completing test validation.

Thanks, wasnt doubting you, i just have a OCD to check sources these days :-)

June 17th snapshot
https://web.archive.org/web/20200617093646/https://www.360dx.com/coronavirus-test-tracker-launched-covid-19-tests

June 24th snapshot
https://web.archive.org/web/20200624210840/https://www.360dx.com/coronavirus-test-tracker-launched-covid-19-tests

Looks like they applied between 17 and 24th June. The archive doesnt record an entry 'EUA submissiong pending' prior to 24th June.

This is from the RNS

MID JUNE
- Indian approval was applied for in mid-June and the process is ongoing. The Company remains very confident that rapid commercial roll out could be achieved in India through both existing distribution partners and DIVOC Health, a new COVID focussed partner in India.


EARLY JUNE
- The Company has signed a number of distributors across Africa and is in the process of registering the product locally. The CoV-2 Test was submitted for WHO approval in early June, although this is not a primary focus for market entry as many African countries have their own approval processes.


NO DATE
- In the United States, Emergency Use Authorisation (EUA) has been applied for and remains under consideration by the FDA. The Company has been in discussion with several interested partners to access the US market, but all discussions have been subject to receipt of EUA approval.